The Fertility Show, Manchester Central, 24-25 March 2018
Page URL:

Huntington's disease in mice partly reversed using CRISPR

26 June 2017
Appeared in BioNews 906

Eliminating the faulty protein that causes Huntington's disease goes some way to reversing disease progression in mice, a study has found.

Scientists used the genome editing technique CRISPR/Cas9 to 'switch off' the disease-causing gene in mice brains, alleviating many associated symptoms, though not to the level of healthy mice.

'The findings open up an avenue for treating Huntington's as well as other inherited neurodegenerative diseases, although more testing of safety and long-term effects is needed,' said Professor Xiao-Jiang Li at Emory University School of Medicine, USA, and senior study author. The work was published in Journal of Clinical Investigation.

Huntington’s disease is a genetic condition caused by a mutant form of the huntingtin gene (mHTT). It produces a toxic protein that accumulates in brain cells and causes progressive cognitive and motor decline, typically in mid-life, eventually leading to death.

The team of researchers used adult mice that contained the human form of the mutant gene, and were already showing signs of the disease. Using CRISPR/Cas9, they introduced genetic changes in an afflicted region of the brain that prevented further production of faulty protein. After three weeks, the mouse brains showed a reduction in the build-up of the mutant protein, and a concomitant improvement in their physical functions - although not to the levels of the control mice.

These observations highlight the ability of brain cells to repair themselves, the researchers believe.

Extending the results to human patients, the authors wrote: 'Thus, reducing mHTT expression in the brains of elder HD patients might still be effective in alleviating neurological symptoms.'

The scientists also sequenced the entire genome of the mice brain cells, which showed that genetic changes had predominantly occurred in the targeted gene. These results follow concerns about the safety and specificity of CRISPR/Cas9 genome editing raised recently, particularly incidences of unwanted mutations and changes in unintended parts of the genome (see BioNews 903).

19 February 2018 - by Hannah Somers 
Researchers have discovered that the protein responsible for the development of Huntington's disease is highly toxic to cancer cells...
11 December 2017 - by Martha Henriques 
A breakthrough trial has successfully reduced levels of the harmful protein that causes the neurodegenerative disease Huntington's...
14 August 2017 - by Emma Lamb and Annabel Slater 
Scientists have repurposed CRISPR to target the repetitive RNA sequences responsible for several genetic diseases...
12 June 2017 - by Lea Goetz 
Scientists have identified the first promising biomarker for Huntington's disease (HD) that could be harnessed in a simple blood test to predict disease onset and progression...
5 June 2017 - by Charlotte Spicer 
CRISPR may introduce hundreds of unwanted mutations into the genome, a small study finds...
22 May 2017 - by Jennifer Willows 
A woman whose father has Huntington’s disease has won the right to sue his doctors for negligence, for failing to tell her...
23 January 2017 - by Annabel Slater 
The fourth session of the Progress Educational Trust's annual conference 'Rethinking the Ethics of Embryo Research: Genome Editing, 14 Days and Beyond' delved into the new genome-editing technique CRISPR/Cas9 and what it means for embryo research...
21 November 2016 - by Paul Waldron 
Scientists in the US have used a genome-editing technique to partially restore vision in blind rats...
17 October 2016 - by Sarah Gregory 
Researchers have used the CRISPR/Cas9 genome-editing technique to correct the mutation that causes sickle-cell anaemia...
12 September 2016 - by Dr Özge Özkaya 
Scientists from China have managed to shrink the size of tumours in mice using CRISPR/Cas9 genome-editing technology...
3 August 2015 - by Dr Victoria Burchell 
A genome-wide study of over 4000 people with Huntington's disease has identified the location several new gene variants that influence the onset of disease symptoms...
25 June 2012 - by Holly Rogers 
A single dose of an 'antisense' drug has been shown to slow, or even partially reverse, Huntington's disease in animal studies, according to a study published in Neuron....
5 July 2010 - by Dr Jay Stone 
Two papers published in the Lancet have suggested that the number of people in the UK suffering with Huntington’s disease (HD) may be double original figures and that patients are failing to be diagnosed due to the stigma attached to the illness...
7 September 2009 - by Ailsa Stevens 
Clinicians should be cautious about offering genetic testing to patients at risk from Huntington's disease to enable them to participate in clinical trials, Dr Sheila Simpson, a Clinical Geneticist at NHS Grampian Hospital, said in a talk at the annual conference of the British Society of Human Genetics at Warwick University....
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.